1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Kohda, D. Inagaki, F. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 31 11928 11939 10.1021/bi00162a036 1445923 Three-dimensional nuclear magnetic resonance structures of mouse epidermal growth factor in acidic and physiological pH solutions. 1992 US Biochemistry BICHAW 0033 0006-2960 31 677 Structure of Epidermal Growth Factor Bound to Perdeuterated Dodecylphosphocholine Micelles Determined by Two-Dimensional NMR and Simulated Annealing Calculations 1992 US Biochemistry BICHAW 0033 0006-2960 30 4896 Characterization of Ph Titration Shifts for All the Nonlabile Proton Resonances in a Protein by Two-Dimensional NMR: The Case of Mouse Epidermal Growth Factor 1991 JA J.Biochem.(Tokyo) JOBIAO 0418 0021-924X 103 741 Tertiary Structure of Mouse Epidermal Growth Factor Determined by Two-Dimensional 1H NMR 1988 AT Biochem.Int. BIINDF 0758 0158-5231 16 647 A Comparative 1H NMR Study of Mouse Alpha(1-53) and Beta(2-53) Epidermal Growth Factors 1988 JA J.Biochem.(Tokyo) JOBIAO 0418 0021-924X 103 554 Complete Sequence-Specific 1H Nuclear Magnetic Resonance Assignments for Mouse Epidermal Growth Factor 1988 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 6050.717 EPIDERMAL GROWTH FACTOR 1 man polymer no no NSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCQTRDLRWWELR NSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCQTRDLRWWELR A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n house mouse Mus sample 10090 Mus musculus pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conf repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1994-01-31 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1992-03-24 REL 1 BRUNGER refinement X-PLOR ASN 1 n 1 ASN 1 A SER 2 n 2 SER 2 A TYR 3 n 3 TYR 3 A PRO 4 n 4 PRO 4 A GLY 5 n 5 GLY 5 A CYS 6 n 6 CYS 6 A PRO 7 n 7 PRO 7 A SER 8 n 8 SER 8 A SER 9 n 9 SER 9 A TYR 10 n 10 TYR 10 A ASP 11 n 11 ASP 11 A GLY 12 n 12 GLY 12 A TYR 13 n 13 TYR 13 A CYS 14 n 14 CYS 14 A LEU 15 n 15 LEU 15 A ASN 16 n 16 ASN 16 A GLY 17 n 17 GLY 17 A GLY 18 n 18 GLY 18 A VAL 19 n 19 VAL 19 A CYS 20 n 20 CYS 20 A MET 21 n 21 MET 21 A HIS 22 n 22 HIS 22 A ILE 23 n 23 ILE 23 A GLU 24 n 24 GLU 24 A SER 25 n 25 SER 25 A LEU 26 n 26 LEU 26 A ASP 27 n 27 ASP 27 A SER 28 n 28 SER 28 A TYR 29 n 29 TYR 29 A THR 30 n 30 THR 30 A CYS 31 n 31 CYS 31 A ASN 32 n 32 ASN 32 A CYS 33 n 33 CYS 33 A VAL 34 n 34 VAL 34 A ILE 35 n 35 ILE 35 A GLY 36 n 36 GLY 36 A TYR 37 n 37 TYR 37 A SER 38 n 38 SER 38 A GLY 39 n 39 GLY 39 A ASP 40 n 40 ASP 40 A ARG 41 n 41 ARG 41 A CYS 42 n 42 CYS 42 A GLN 43 n 43 GLN 43 A THR 44 n 44 THR 44 A ARG 45 n 45 ARG 45 A ASP 46 n 46 ASP 46 A LEU 47 n 47 LEU 47 A ARG 48 n 48 ARG 48 A TRP 49 n 49 TRP 49 A TRP 50 n 50 TRP 50 A GLU 51 n 51 GLU 51 A LEU 52 n 52 LEU 52 A ARG 53 n 53 ARG 53 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N TYR 3 A N TYR 3 A O HIS 22 A O HIS 22 A N MET 21 A N MET 21 A O THR 30 A O THR 30 A N SER 38 A N SER 38 A O THR 44 A O THR 44 1 A TYR 37 0.087 SIDE CHAIN 1 A ARG 41 0.317 SIDE CHAIN 1 A ARG 48 0.309 SIDE CHAIN 1 A ARG 53 0.211 SIDE CHAIN 1 5.78 0.90 109.00 114.78 A A A CD1 NE1 CE2 TRP TRP TRP 49 49 49 N 1 7.44 1.10 130.40 137.84 A A A NE1 CE2 CZ2 TRP TRP TRP 49 49 49 N 1 -7.05 1.00 110.10 103.05 A A A CG CD1 NE1 TRP TRP TRP 50 50 50 N 1 6.34 0.90 109.00 115.34 A A A CD1 NE1 CE2 TRP TRP TRP 50 50 50 N 1 7.27 1.10 130.40 137.67 A A A NE1 CE2 CZ2 TRP TRP TRP 50 50 50 N 1 A A CG ND1 HIS HIS 22 22 -0.105 0.015 1.369 1.264 N 1 A A CG CD2 TRP TRP 50 50 -0.103 0.017 1.432 1.329 N 1 A SER 2 71.42 -8.77 1 A TYR 3 41.98 95.42 1 A PRO 7 -37.81 123.07 1 A SER 9 -47.04 -19.33 1 A TYR 10 -84.78 -76.55 1 A ASP 11 30.29 29.97 1 A ASN 16 34.93 101.92 1 A SER 25 -44.57 -80.78 1 A ASP 27 50.56 17.76 1 A SER 28 -75.46 -167.34 1 A CYS 33 -64.11 -146.93 1 A VAL 34 -162.21 -163.20 1 A ILE 35 -68.05 54.26 1 A SER 38 -161.20 -160.53 1 A ASP 40 -46.50 -93.42 1 A CYS 42 -171.93 32.61 1 A THR 44 -103.57 79.10 1 A LEU 47 -62.54 73.03 1 A ARG 48 -147.20 -93.67 1 A TRP 49 -32.63 -88.09 1 A TRP 50 -44.73 -18.25 1 A GLU 51 47.81 -90.45 1 A LEU 52 172.61 127.18 model building X-PLOR refinement X-PLOR phasing X-PLOR EPIDERMAL GROWTH FACTOR (EGF) IN PH 2 SOLUTION (NMR, MINIMIZED MEAN STRUCTURE) THREE-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE STRUCTURES OF MOUSE EPIDERMAL GROWTH FACTOR IN ACIDIC AND PHYSIOLOGICAL PH SOLUTIONS 1 Y N disulf 2.019 A CYS 6 A SG CYS 6 1_555 A CYS 20 A SG CYS 20 1_555 disulf 2.016 A CYS 14 A SG CYS 14 1_555 A CYS 31 A SG CYS 31 1_555 disulf 2.016 A CYS 33 A SG CYS 33 1_555 A CYS 42 A SG CYS 42 1_555 EPIDERMAL GROWTH FACTOR EPIDERMAL GROWTH FACTOR EGF_MOUSE UNP 1 1 P01132 MPWGRRPTWLLLAFLLVFLKISILSVTAWQTGNCQPGPLERSERSGTCAGPAPFLVFSQGKSISRIDPDGTNHQQLVVDA GISADMDIHYKKERLYWVDVERQVLLRVFLNGTGLEKVCNVERKVSGLAIDWIDDEVLWVDQQNGVITVTDMTGKNSRVL LSSLKHPSNIAVDPIERLMFWSSEVTGSLHRAHLKGVDVKTLLETGGISVLTLDVLDKRLFWVQDSGEGSHAYIHSCDYE GGSVRLIRHQARHSLSSMAFFGDRIFYSVLKSKAIWIANKHTGKDTVRINLHPSFVTPGKLMVVHPRAQPRTEDAAKDPD PELLKQRGRPCRFGLCERDPKSHSSACAEGYTLSRDRKYCEDVNECATQNHGCTLGCENTPGSYHCTCPTGFVLLPDGKQ CHELVSCPGNVSKCSHGCVLTSDGPRCICPAGSVLGRDGKTCTGCSSPDNGGCSQICLPLRPGSWECDCFPGYDLQSDRK SCAASGPQPLLLFANSQDIRHMHFDGTDYKVLLSRQMGMVFALDYDPVESKIYFAQTALKWIERANMDGSQRERLITEGV DTLEGLALDWIGRRIYWTDSGKSVVGGSDLSGKHHRIIIQERISRPRGIAVHPRARRLFWTDVGMSPRIESASLQGSDRV LIASSNLLEPSGITIDYLTDTLYWCDTKRSVIEMANLDGSKRRRLIQNDVGHPFSLAVFEDHLWVSDWAIPSVIRVNKRT GQNRVRLQGSMLKPSSLVVVHPLAKPGADPCLYRNGGCEHICQESLGTARCLCREGFVKAWDGKMCLPQDYPILSGENAD LSKEVTSLSNSTQAEVPDDDGTESSTLVAEIMVSGMNYEDDCGPGGCGSHARCVSDGETAECQCLKGFARDGNLCSDIDE CVLARSDCPSTSSRCINTEGGYVCRCSEGYEGDGISCFDIDECQRGAHNCAENAACTNTEGGYNCTCAGRPSSPGRSCPD STAPSLLGEDGHHLDRNSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCQTRDLRWWELRHAGYGQKHDIM VVAVCMVALVLLLLLGMWGTYYYRTRKQLSNPPKNPCDEPSGSVSSSGPDSSSGAAVASCPQPWFVVLEKHQDPKNGSLP ADGTNGAVVDAGLSPSLQLGSVHLTSWRQKPHIDGMGTGQSCWIPPSSDRGPQEIEGNSHLPSYRPVGPEKLHSLQSANG SCHERAPDLPRQTEPVK 977 1029 1EPG 1 53 P01132 A 1 1 53 3 2 anti-parallel anti-parallel anti-parallel A SER 2 A SER 2 A PRO 4 A PRO 4 A VAL 19 A VAL 19 A ILE 23 A ILE 23 A SER 28 A SER 28 A ASN 32 A ASN 32 A TYR 37 A TYR 37 A SER 38 A SER 38 A THR 44 A THR 44 A ARG 45 A ARG 45 1 P 1